NEW YORK--(BUSINESS WIRE)--May 15, 2023--
Building upon over a decade of experience providing high-quality, real-world oncology data, Flatiron Health has announced the expansion of their real-world evidence (RWE) offerings to include analytic, scientific, and consultative services, leveraging the high-quality foundational real-world data (RWD) assets that the company is well known for. Flatiron’s new Integrated RWE Solutions will include data and end-to-end services to provide a more flexible and fit-for-purpose approach to address growing oncology RWE needs—from early development through late stage commercialization.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230515005141/en/
(Graphic: Business Wire)
“This is a natural and exciting evolution for Flatiron. As experts in data extraction from our clinical EHR and deep curation for life sciences research, we’ve developed extensive “data empathy,” a multi-faceted, detailed knowledge and understanding of oncology EHR data. During that time, we’ve also built a world-class team of oncologists, researchers, and health data analysts who understand the intricacies of RWE generation for oncology,” said Stephanie Reisinger, SVP & General Manager, Real-World Evidence. “This expansion will enable us to provide flexible, end-to-end evidence solutions focused on our customers’ needs—whether it is the delivery of a custom oncology dataset or the execution of an oncology research project to answer a pressing clinical question. We’re building upon our unique expertise and market position as the leading oncology EHR data provider, with a goal to become our clients’ oncology RWE partner of choice.
The Integrated RWE Solutions approach provides customers with a more flexible way to engage with Flatiron, delivering oncology evidence solutions tailored to fit customers’ unique needs. As Flatiron has established itself as the oncology RWD partner of choice for many pharmaceutical companies, this expansion establishes an expert, one-stop-shop for oncology RWD/E generation. The approach also minimizes risks associated with RWD studies, as the scientists and clinicians who will be executing these studies have a deep understanding of the complexities and nuances of the oncology EHR as applied to the development of RWE.
As the leader in oncology RWD, Flatiron has built the extraction and curation infrastructure necessary to provide high-quality data for real-world oncology research. Flatiron’s RWD is integrated at the source through OncoEMR®, allowing data to be auditable and traceable back to source documents. Flatiron’s ability to operate as a fully integrated solutions company enables practicing oncology physicians and clinicians to oversee data curation methods and lead the development of complex data variables appropriate for oncology research. Using a combination of machine learning and human approaches, Flatiron generates deep, high-quality data content with the scale required for most oncology evidence generation needs.
“Flatiron has been a valuable partner, bringing their expertise and newly expanded strategic offerings in real-world data analytics to the table,” said WW HEOR Director, Large Global Life Sciences Company. “Their seamless collaborative approach and subject matter knowledge advanced a real-world comparative effectiveness study evaluating treatment-specific sub-cohorts within a broader, real-world biomarker-identified population. Flatiron’s scientific innovation and breadth of analytic capabilities have greatly contributed to generating impactful evidence for this oncology research project.”
About Flatiron Health
Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group. Flatiron.com @FlatironHealth
About Integrated RWE Solutions
Flatiron’s Integrated Real-World Evidence Solutions transform the possibilities of oncology research, development, and commercialization. Whether you're tackling bold research questions or time-critical decision points along the way, our solutions deliver the data, tools, and support you need to achieve your goals faster and more efficiently than ever before.
View source version on businesswire.com:https://www.businesswire.com/news/home/20230515005141/en/
CONTACT: Media ContactsFlatiron Health
Nina Toor
communications@flatiron.com
KEYWORD: NEW YORK UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: TECHNOLOGY MANAGED CARE GENERAL HEALTH HOSPITALS SCIENCE GENETICS CLINICAL TRIALS FDA BIOTECHNOLOGY HEALTH HEALTH TECHNOLOGY OTHER SCIENCE RESEARCH SOFTWARE PHARMACEUTICAL DATA MANAGEMENT ONCOLOGY
SOURCE: Flatiron Health
Copyright Business Wire 2023.
PUB: 05/15/2023 09:00 AM/DISC: 05/15/2023 09:02 AM
http://www.businesswire.com/news/home/20230515005141/en
